News

Search For News


TRY IT NOW

Sign up online today & collaborate

or click here to find out more

Search results for {{term}}

1. Malin Corporation plc Appoints Peter Schwartzman to Senior Management

Malin Corporation plc Appoints Peter Schwartzman to Senior Management Team07/10/2016Malin Corporation plc. (ISE:MLC, "Malin"), an Irish-based global life sciences company, today announced the appointment of Peter Schwartzman to the company's senior team, effective immediately. Peter Schwartzman brings 30 years of experience in asset and risk management to Malin. He was most recently a Managing Director in the Leveraged Finance Group within BlackRock Financial Management - the world's larges


2. Oxford Immunotec Announces Closing of $40 Million in Debt Financing

Oxford Immunotec Announces Closing of $40 Million in Debt Financing05/10/2016Oxford, UK & Marlborough, USA – Oxford Immunotec Global PLC, a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of under-served immune-regulated conditions, today announced that it has entered into an agreement with MidCap Financial (“MidCap”) that provides the Company with $40 million in debt financing, comprised


3. Wickham Laboratories Announces Renewal of FDA Accreditation

Wickham Laboratories Announces Renewal of FDA Accreditation 17/10/2016Wickham Laboratories reports a successful completion of the FDA auditing process with renewal of GMP accreditation.Gosport, UK – Wickham Laboratories announces that the United States Food and Drug Administration (FDA) inspection conducted 15th-17th of February 2016 has now been closed out and our accreditation is renewed for a further term. This multi-day inspection assessed our compliance with Good Manufacturing Pr


4. An exceptional year for the PiR team

An exceptional year for the PiR team09/11/2016St Ives, UK – 2016 has proven to be a phenomenal year of success and growth for the specialist life science recruitment company PiR. Team work, client engagement and an in-depth understanding of the market have resulted in PiR’s most exciting and rewarding year to date, as it continues to work with an outstanding array of companies in the innovative early stage life science space.Sally Hope, MD of PiR, commented: “Our success is dir


5. Horizon Discovery and CareDx Enter into OEM Agreement for Routine Incl

Horizon Discovery and CareDx Enter into OEM Agreement for Routine Inclusion of Cell-Free DNA Reference Standards in Transplant Testing09/11/2016· Agreement builds on existing collaboration to develop cell-free DNA (cfDNA) Reference Standards to support CareDx’s solid organ transplant injury monitoring tests· Ongoing collaboration supports strategy to provide reliable revenue through the inclusion of Horizon’s HDxTM Reference Standards in established assay workflowsHorizon D



Page 17 of 30 ( 148 results in total )
© Catalyst Innovation Portal 2018